Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 466 across all filing types
Latest filing 2011-11-09 Share Issue/Capital Cha…
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Generix Group : Information relative au nombre total de droits de vote et d'actions au 31 octobre 2011
Share Issue/Capital Change Classification · 95% confidence The document is very short (518 characters) and explicitly states it provides information regarding the 'nombre total de droits de vote et d'actions' (total number of voting rights and shares) as required by French commercial code and AMF regulations. This structure, which typically involves a small table reporting share counts and voting rights as of a specific date (31/10/2011), is characteristic of a mandatory regulatory disclosure concerning share capital structure, often related to a general meeting or significant ownership changes. Given the options, this specific disclosure about the total number of shares and voting rights most closely aligns with the general regulatory disclosure category, as it is not a full report (10-K, IR), an earnings release (ER), or a specific director dealing report (DIRS). While it relates to voting rights, it is a factual disclosure of the total count, not the results of a vote (DVA). Therefore, the most appropriate general classification for this mandatory regulatory update on share capital structure is Regulatory Filings (RNS).
2011-11-09 French
Generix Group : Report de la date de publication du rapport financier semestriel au 30 novembre 2011
Report Publication Announcement Classification · 99% confidence The document is titled "Report de la date de publication du rapport financier semestriel au 30 novembre 2011" (Report on the publication date of the semi-annual financial report for November 30, 2011). The text explicitly states that the publication of the semi-annual financial report, initially scheduled for November 17, 2011, is postponed to November 30, 2011. This is an announcement about the timing of a future report release, not the report itself. According to Rule 2 (The 'Menu vs Meal' Rule), a document announcing the timing or publication of a report falls under Report Publication Announcement (RPA). The document length (1472 chars) is short, supporting this classification.
2011-11-08 French
Generix Group : Complément au communiqué en date du 19 octobre 2011
Share Issue/Capital Change Classification · 99% confidence The document is a communiqué dated October 20, 2011, which explicitly states it is a 'Complément au communiqué en date du 19 octobre 2011' (Supplement to the press release dated October 19, 2011). It details a change in ownership percentage following a financial operation ('Pléiade Investissement... détiendra... 48,92 % du capital'). The content focuses on ownership structure changes resulting from a transaction, likely related to fundraising or capital restructuring, and includes extensive disclaimers typical of securities offerings (mentioning Prospectus Directive, Securities Act of 1933, etc.). This strongly indicates an announcement related to capital raising or financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2011-10-21 French
Generix Group announces second quarter revenues of financial year 2011/2012
Earnings Release Classification · 99% confidence The document explicitly announces 'revenues for the second quarter, ended September 30, 2011' and presents summarized financial data for that quarter and the preceding six months. This content structure—a brief announcement highlighting key figures for a period shorter than a full year—is characteristic of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial release of period results. The document length (3430 chars) is short, but it contains the core financial highlights, making ER more appropriate than RPA or RNS, which are typically just announcements *about* a report. Q2 2011
2011-10-20 English
Generix Group annonce son chiffre d'affaires pour le second trimestre de son exercice 2011/2012
Earnings Release Classification · 98% confidence The document is titled "Generix Group annonce son chiffre d'affaires pour le deuxième trimestre de son exercice 2011/2012" (Generix Group announces its revenue for the second quarter of its 2011/2012 fiscal year). It explicitly states the revenue figures for the second quarter (Q2) and the first six months, including detailed tables comparing 2011 and 2010 figures. This content is characteristic of an initial announcement of periodic financial results, focusing on key figures rather than a comprehensive report or management discussion. This aligns perfectly with the definition of an Earnings Release (ER). Furthermore, the document is short and announces the next step: the publication of the half-year results, suggesting this is the preliminary release for the quarter/period just ended. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but the initial release of results. Q2 2012
2011-10-20 French
Generix Group : Succès de l'augmentation de capital de Generix Group d'un montant de 8,3 millions d'euros avec maintien du droit préférentiel de souscription
Capital/Financing Update Classification · 98% confidence The document is a press release dated October 19, 2011, announcing the successful completion of a capital increase ('augmentation de capital') for Generix Group, raising 8.3 million euros through the issuance of new shares using a preferential subscription right. This event directly relates to changes in the company's capital structure and fundraising activities. Based on the definitions, the most appropriate category is 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA/RNS), as it contains the substantive details of the financing operation itself.
2011-10-19 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.